Trials / Completed
CompletedNCT01971385
Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
A Clinical Trial to Test the Safety and Efficacy of Squaric Acid Dibutyl Ester for the Treatment of Herpes Labialis
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Subjects with a history of recurrent herpes labialis will be sensitized with either 2% SADBE or placebo. Following this, subjects sensitized with 2% SADBE will received.2% sqauric acid or.5% squaric acid on their cold sore within 72 hours of a recurrence. Subjects sensitized with placebo solution will receive placebo solution on their cold sore within 72 hours of a recurrence. Subjects will be followed for up to 6 mos after application of study medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Squaric Acid solution | |
| DRUG | Placebo solution |
Timeline
- Start date
- 2013-10-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2013-10-29
- Last updated
- 2017-10-02
- Results posted
- 2017-10-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01971385. Inclusion in this directory is not an endorsement.